Taiko Pharmaceutical Income Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	6,397	6,292	6,120	5,040	11,299
Revenue Growth (YoY)	1.67%	2.81%	21.43%	-55.39%	-49.68%
Cost of Revenue	2,916	2,626	3,543	3,961	8,552
Gross Profit	3,481	3,666	2,577	1,079	2,747
Selling, General & Admin	3,022	3,036	3,583	4,157	7,694
Operating Expenses	3,022	3,036	3,583	4,157	7,694
Operating Income	459	630	-1,006	-3,078	-4,947
Interest Expense	-5	-8	-8	-10	-6
Interest & Investment Income	16	30	25	5	3
Currency Exchange Gain (Loss)	138	39	31	59	50
Other Non Operating Income (Expenses)	3	-2	-291	-330	-1,231
EBT Excluding Unusual Items	611	689	-1,249	-3,354	-6,131
Gain (Loss) on Sale of Investments	347	6	193	-82	60
Gain (Loss) on Sale of Assets	-	-	76	-	-
Asset Writedown	-26	-240	-2,506	-98	-2,456
Legal Settlements	-	-	-	-499	-359
Other Unusual Items	14	111	-78	-837	-2
Pretax Income	958	566	-3,564	-4,870	-8,888
Income Tax Expense	35	-332	47	25	706
Net Income	923	898	-3,611	-4,895	-9,594
Net Income to Common	923	898	-3,611	-4,895	-9,594
Net Income Growth	2.78%	-	-	-	-
Shares Outstanding (Basic)	50	50	47	44	44
Shares Outstanding (Diluted)	50	50	47	44	44
Shares Change (YoY)	0.11%	5.96%	8.62%	0.21%	0.35%
EPS (Basic)	18.37	17.89	-76.25	-112.27	-220.51
EPS (Diluted)	18.37	17.89	-76.25	-112.27	-220.51
EPS Growth	2.67%	-	-	-	-
Free Cash Flow	523	205	-404	-2,058	-3,071
Free Cash Flow Per Share	10.41	4.08	-8.53	-47.20	-70.58
Dividend Per Share	3.300	-	-	-	-
Gross Margin	54.42%	58.26%	42.11%	21.41%	24.31%
Operating Margin	7.17%	10.01%	-16.44%	-61.07%	-43.78%
Profit Margin	14.43%	14.27%	-59.00%	-97.12%	-84.91%
Free Cash Flow Margin	8.18%	3.26%	-6.60%	-40.83%	-27.18%
EBITDA	724	886	-302	-2,341	-4,006
EBITDA Margin	11.32%	14.08%	-4.93%	-46.45%	-35.45%
D&A For EBITDA	265	256	704	737	941
EBIT	459	630	-1,006	-3,078	-4,947
EBIT Margin	7.17%	10.01%	-16.44%	-61.07%	-43.78%
Effective Tax Rate	3.65%	-	-	-	-
Advertising Expenses	-	767	979	806	3,005

Source: S&P Global Market Intelligence. Standard template. Financial Sources.